TLK286
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for TLK286, covering 2011-07-25 to 2013-06-26. Get the full timeline:
Most recent: Clinical Trial Update: TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]